Z-alpha1-antitrypsin polymers and small airways disease: a new paradigm in COPD development? Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020
Just correlations? Unravelling the origins of the asthma epidemic Source: Annual Congress 2008 - Sadoul Lecture Year: 2008
MicroRNAs in COPD: small molecules with big potential Source: Eur Respir J, 53 (4) 1900515; 10.1183/13993003.00515-2019 Year: 2019
The environment, epigenetics and lung disease Source: Annual Congress 2013 –PG6 Epigenetics of asthma and COPD Year: 2013
Small airways and early origins of COPD: pathobiological and epidemiological considerations Source: Eur Respir J, 55 (3) 1902457; 10.1183/13993003.02457-2019 Year: 2020
Making progress toward understanding the genetic architecture of asthma in the most affected US ethnic group Source: Eur Respir J, 49 (5) 1700329; 10.1183/13993003.00329-2017 Year: 2017
Omics in population studies: a molecular epidemiology perspective in chronic airway disease Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome Year: 2014
Clinical asthma phenotypes in the real world: opportunities and challenges Source: Breathe 2015; 11:186-193 Year: 2015
New approaches to the understanding of complex chronic lung diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=345 Year: 2006
Facing the challenges of self-management in COPD: how do people adapt to the disease, its symptoms and resulting limitations? Source: Eur Respir J 2005; 26: Suppl. 49, 310s Year: 2005
Systems biology and big data in asthma and allergy: recent discoveries and emerging challenges Source: Eur Respir J, 55 (1) 1900844; 10.1183/13993003.00844-2019 Year: 2020
The scale of the problem of obstructive lung disease in Africa becomes clearer, but where are the solutions? Source: Eur Respir J, 51 (2) 1702562; 10.1183/13993003.02562-2017 Year: 2018
Chronic diseases like asthma and COPD: do they truly exist? Source: Eur Respir J 2016; 47: 359-361 Year: 2016
What's in a name? That which we call IPF, by any other name would act the same Source: Eur Respir J, 51 (5) 1800692; 10.1183/13993003.00692-2018 Year: 2018
Understanding patients' needs: the impact of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 69s Year: 2003